Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant FMS Like Tyrosine Kinase 3 (Flt3) | Login | Recombinant FMS Like Tyrosine Kinase 3 (Flt3) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant FMS Like Tyrosine Kinase 3 Ligand (Flt3L) | Login | Recombinant FMS Like Tyrosine Kinase 3 Ligand (Flt3L) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Hepatocyte Growth Factor (HGF) | Login | Recombinant Hepatocyte Growth Factor (HGF) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) | Login | Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1) | Login | Recombinant Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1) | Login | Recombinant Receptor Tyrosine Kinase Like Orphan Receptor 1 (ROR1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Absent In Melanoma 2 (AIM2) | Login | Recombinant Absent In Melanoma 2 (AIM2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Mdm2 p53 Binding Protein Homolog (MDM2) | Login | Recombinant Mdm2 p53 Binding Protein Homolog (MDM2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Proteasome Subunit Alpha Type 7 (PSMa7) | Login | Recombinant Proteasome Subunit Alpha Type 7 (PSMa7) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Epithelial Stromal Interaction 1, Breast (EPSTI1) | Login | Recombinant Epithelial Stromal Interaction 1, Breast (EPSTI1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Proteasome Subunit Alpha Type 5 (PSMa5) | Login | Recombinant Proteasome Subunit Alpha Type 5 (PSMa5) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) | Login | Recombinant Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Absent In Melanoma 1 (AIM1) | Login | Recombinant Absent In Melanoma 1 (AIM1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Transcription Termination Factor, RNA polymerase I (TTF1) | Login | Recombinant Transcription Termination Factor, RNA polymerase I (TTF1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) | Login | Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) | Login | Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) | Login | Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 9 (Bcl9) | Login | Recombinant B-Cell CLL/Lymphoma 9 (Bcl9) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant B-Cell CLL/Lymphoma 11A (Bcl11A) | Login | Recombinant B-Cell CLL/Lymphoma 11A (Bcl11A) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Neural Cell Adhesion Molecule 2 (NCAM2) | Login | Recombinant Neural Cell Adhesion Molecule 2 (NCAM2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Testis Anion Transporter 1 (TAT1) | Login | Recombinant Testis Anion Transporter 1 (TAT1) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Myosin Heavy Chain 11, Smooth Muscle (MYH11) | Login | Recombinant Myosin Heavy Chain 11, Smooth Muscle (MYH11) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Thyroid Stimulating Hormone Beta (TSHb) | Login | Recombinant Thyroid Stimulating Hormone Beta (TSHb) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Hexokinase 2 (HK2) | Login | Recombinant Hexokinase 2 (HK2) | ||||||||||||||||
|
||||||||||||||||||
| Recombinant Myosin Light Chain 6B, Alkali, Smooth Muscle And Non Muscle (MYL6B) | Login | Recombinant Myosin Light Chain 6B, Alkali, Smooth Muscle And Non Muscle (MYL6B) | ||||||||||||||||
|
||||||||||||||||||


